Vaccine Supply

Wyeth stops making two vaccines

Published in Vaccine Weekly, December 18th, 2002

Wyeth has ended production of its pneumonia and influenza shots, increasing the country's vulnerability to vaccine shortages.

The pharmaceutical company wants to focus on new immunization technologies such as its experimental nasal spray flu vaccine. But the move means there will only be one company in the United States manufacturing a pneumonia vaccine and another one making an influenza vaccine. Over the last two flu seasons there has been a vaccine shortage.

"It's obviously a concern," Curtis Allen, spokesman for the U.S. Centers for Disease Control and Prevention, said. "The future will depend on the ability of the remaining manufacturers to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2002-12-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry